Tenet Healthcare Corporation (THC)
| Market Cap | 15.57B |
| Revenue (ttm) | 21.31B |
| Net Income (ttm) | 1.41B |
| Shares Out | 87.61M |
| EPS (ttm) | 15.49 |
| PE Ratio | 11.51 |
| Forward PE | 10.37 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 545,568 |
| Open | 187.18 |
| Previous Close | 185.53 |
| Day's Range | 178.00 - 188.04 |
| 52-Week Range | 121.83 - 247.21 |
| Beta | 1.50 |
| Analysts | Buy |
| Price Target | 237.90 (+33.85%) |
| Earnings Date | Apr 30, 2026 |
About THC
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient... [Read more]
Financial Performance
In 2025, Tenet Healthcare's revenue was $21.31 billion, an increase of 3.07% compared to the previous year's $20.68 billion. Earnings were $1.41 billion, a decrease of -56.03%.
Financial StatementsAnalyst Forecast
According to 21 analysts, the average rating for THC stock is "Buy." The 12-month stock price target is $237.9, which is an increase of 33.85% from the latest price.
News
Tenet to Report its First Quarter 2026 Results on April 30th
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its first quarter 2026 results before the market opens on Thursday, April 30, 2026, to be followed by a conference call a...
Tenet Healthcare Transcript: Barclays 28th Annual Global Healthcare Conference
Strong demand for high-acuity care and disciplined capital deployment support robust growth projections. AI and automation drive efficiency, while commercial rates remain favorable and ambulatory expansion continues. Capital priorities include service line investment, share buybacks, and debt reduction.
Tenet to Participate in the Barclays 28th Annual Global Healthcare Conference
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026, beginning at 9:30 a.m. Ea...
Tenet Healthcare Quarterly Profit Surges As Hospital, Surgery Demand Grows
Tenet Healthcare Corporation (NYSE: THC) reported fourth-quarter sales of $5.527 billion, up around 8.9% year over year.
Tenet Healthcare Earnings Call Transcript: Q4 2025
2025 saw strong revenue and margin growth, with Adjusted EBITDA up 14% and robust free cash flow. 2026 guidance anticipates continued growth, though headwinds from expiring tax credits are expected. Capital deployment remains focused on M&A, share repurchases, and technology-driven efficiencies.
Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended December 31, 2025. "2025 extended Tenet's track record of strong revenue gro...
Tenet Healthcare Transcript: Status update
An accretive $2.65 billion asset sale of Conifer's contract with CommonSpirit strengthens cash flow, returns full strategic control, and enables accelerated investment in automation, AI, and offshoring. Capital allocation priorities remain focused on share repurchases and USPI growth.
Tenet Announces Accretive Transaction and Previews Strong 2025 Results
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the completion of a strategic transaction with CommonSpirit Health involving Tenet's Conifer Health Solutions subsidia...
Hospitals Face Profit Squeeze As Policy Risks Grow: Analyst
As the healthcare sector grapples with ongoing regulatory shifts and economic pressures, hospitals find themselves navigating a challenging landscape shaped by policy changes and financial constraints...
Tenet to Report its Fourth Quarter 2025 Results on February 11th
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its fourth quarter 2025 results before the market opens on Wednesday, February 11, 2026, to be followed by a conference c...
Insurers Slide As Congress Postpones Decision On Health Subsidies, Delays Obamacare Subsidy Vote To December
Shares of major health insurers slid Monday as investors reacted to a Senate deal that ended the 40-day U.S. government shutdown but failed to extend subsidies under the Affordable Care Act (ACA).
Tenet Announces Upsizing and Pricing of Its $2.25 Billion Private Offerings of Senior Secured Notes and Senior Notes
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $1.5 billion in ag...
Tenet Announces Private Offerings of Senior Secured Notes and Senior Notes to Refinance $2.0 Billion in Outstanding Notes
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced private placement offerings of $1.5 billion in aggregate principal amount of new senior secured first lien notes due 2...
Tenet Healthcare Earnings Call Transcript: Q3 2025
Q3 2025 saw strong revenue and EBITDA growth, margin expansion, and robust free cash flow, prompting raised full-year guidance for revenue, EBITDA, and capital expenditures. USPI and hospital segments both delivered solid performance, with continued M&A activity and disciplined cost controls supporting future growth.
Tenet Reports Strong Third Quarter 2025 Results; Raises 2025 Financial Outlook
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended September 30, 2025. "Our high acuity service line focus and operational disc...
Tenet to Report Its Third Quarter 2025 Results on October 28th
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its third quarter 2025 results before the market opens on Tuesday, October 28, 2025, to be followed by a conference call ...
Tenet Healthcare Transcript: Wells Fargo 20th Annual Healthcare Conference 2025
Earnings and free cash flow guidance were raised, driven by strong core performance and margin expansion. Policy focus is on extending premium tax credits and Medicaid payments, while capital investment is increasing in high-acuity and ambulatory growth. Operational efficiency and cost control remain priorities.
Tenet to Participate in the 2025 Wells Fargo Healthcare Conference
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3, 2025, beginning at 9:30 a.m. Eastern ...
Top 3 stocks to buy with strong cash flow and sizable buyback programme
In a market where capital discipline and shareholder returns are increasingly prized, companies with robust free cash flows and aggressive share repurchase plans stand out. Buybacks not only reduce sh...
Tenet and USPI Named Foundational Sponsor of Inaugural AAOS Launchpad Program
Strategic partnership aims to empower PGY5 orthopaedic residents with critical tools, mentorship, and resources for a successful transition into practice ROSEMONT, Ill. , Aug. 20, 2025 /PRNewswire/ --...
These Analysts Boost Their Forecasts On Tenet Healthcare After Upbeat Q2 Results
Tenet Healthcare Corporation THC posted better-than-expected earnings for the second quarter on Tuesday.
Tenet Healthcare Earnings Call Transcript: Q2 2025
Q2 2025 saw 19% adjusted EBITDA growth and margin expansion, with strong USPI and hospital performance. Full-year guidance was raised for revenue, EBITDA, and free cash flow, supported by high-acuity strategies and robust payer mix.
Tenet Reports Strong Second Quarter 2025 Results; Raises 2025 Financial Outlook
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended June 30, 2025. "Our strong second quarter results extend our track record of...
Tenet to Report its Second Quarter 2025 Results on July 22nd
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its second quarter 2025 results before the market opens on Tuesday, July 22nd, 2025, to be followed by a conference call ...